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Abstract: Suicidal behavior is a problem with important social repercussions. Some groups of 
the population show a higher risk of suicide; for example, depression, alcoholism, psychosis or 
drug abuse frequently precedes suicidal behavior. However, the relationship between metabolic 
alterations in the brain and premorbid clinical symptoms of suicide remains uncertain. The 
serotonergic and noradrenergic systems have frequently been, implicated in suicidal behavior 
and the amount of serotonin in the brain and CSF of suicide victims has been found to be low 
compared with normal subjects. However, there are contradictory results regarding the role of 
noradrenergic neurons in the mediation of suicide attempts, possibly reﬂ  ecting the heterogeneity 
of conditions that lead to a common outcome. In the present work we focus on the subgroup 
of suicide victims that share a common diagnosis of major depression. Based on post-mortem 
studies analyzing mRNA expression by in situ hybridization, serotonergic neurons from the 
dorsal raphe nucleus (DRN) from depressive suicide victims are seen to over-express cyto-
chrome oxidase mRNA. However, no corresponding changes were found in the expression of 
tyrosine hydroxylase (TH) mRNA in the noradrenergic neurons of the Locus Coeruleus (LC). 
These results suggest that, despite of the low levels of serotonin described in suicide victims, 
the activity of DRN neurons could increase in the suicidally depressed, probably due to the over 
activation of serotonin re-uptake. No alteration was found in noradrenergic neurons, suggesting 
that they play no crucial role in the suicidal behavior of depressive patients.
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Suicidal behavior is an important and grave social problem with complex and intricate 
clinical implications which might constitute the ﬁ  nal outcome of several psychiatric 
conditions (although it may also be an existential choice, in some cases) (Leboyer 
et al 2005). Among the neurotransmitters associated with neuropsychiatric disorders, 
noradrenaline and serotonin are closely associated with depression and suicide. The 
amount of serotonin (5-HT) or its metabolite, 5-hydroxyindoleacetic acid (5-HIAA), 
is lower in the brainstem and CSF of suicide victims than in normal subjects (Shaw 
et al 1967; Shaw 1967; Bourne et al 1968; Pare et al 1969; Lloyd et al 1974; Mann et al 
2000; Arango et al 1992; Nordstrom and Asberg 1992). In addition, suicidal behavior 
has been associated with low activity of the serotonin transporter gene (Courtet et al 
2001), which could partially explain the high risk of suicidal attempts observed in 
certain families (Brent et al 2002; Rujescu et al 2007). The noradrenergic system is 
also thought to be associated with suicidal behavior. Some authors have found that 
the levels of tyrosine hydroxylase (TH) are increased in neurons from the Locus Coe-
ruleus (LC) of suicide victims (Ordway et al 1994; Ordway 1997) while others have 
observed that the number of noradrenergic neurons appears to be lower in suicide Neuropsychiatric Disease and Treatment 2008:4(2) 414
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victims and patients suffering major depression (Arango et al 
1996). The seemingly contradictory ﬁ  ndings in post-mortem 
studies as regards LC neurons may reﬂ  ect the heterogeneity 
of conditions in which suicide victims are exposed.
In the present work, we have focused our investigation 
specifically on a subgroup of suicidal victims, previ-
ously diagnosed with major depression. We analyze the 
serotonergic and noradrenergic systems measuring, by in 
situ hybridization, the mRNA expression of cytochrome 
oxidase (CO), a nonspeciﬁ  c mitochondrial protein that has 
been widely used as an index of neuronal activity (Herrero 
et al 1996; Vila et al 1996; Levy et al 1997), in neurons of 
the dorsal raphe nucleus (DRN) (Jacobs 1986; Birkett and 
Fite 2005). We also analyze mRNA expression of TH in 
LC neurons, which may be a marker of increased neuronal 
activity of brains from suicide victims and control subjects 
dying from other causes.
The study was performed in brainstems obtained from six 
Caucasian subjects (average age, 48 ± 11 years) who had been 
diagnosed with major depression prior to their committing 
suicide (3 males and 3 females) and 5 age-matched controls 
(2 males and 3 females) dying of natural or accidental causes 
without any cerebral damage.
Brain tissue was obtained from autopsies performed at 
the Instituto Médico Legal (Murcia Spain). The study was 
performed according to the policies and ethical rules of the 
institutions involved. Suicide victims did not present altera-
tions due to abuse of or dependence on psychoactive drugs.
The brainstem was separated and sectioned along the 
midline, and half of each block was frozen in isopentane with 
liquid nitrogen and then stored at −80 °C. Frozen brainstems 
were sectioned with a cryostat into 20 µm sections at −19 °C 
and thaw-mounted on gelatin-coated slides.
Experimental procedures of the in situ hybridization 
technique and validation of the quantiﬁ  cation of the optical 
density have been described elsewhere (Kastner et al 1994; 
Herrero et al 1996; Vila et al 1996, 1997; Levy et al 1997). 
Brieﬂ  y, slide-mounted sections were dried at room tempera-
ture and post-ﬁ  xed in 3% paraformaldehyde in potassium 
phosphate buffer (pH = 7.4) for 30 minutes. Then, sections 
were treated with 0.25% acetic anhydride in 0.1 mM ethanol-
amine (pH = 8) followed by 0.1 M glycine and dehydration 
in increasing concentrations of ethanol. Sections were then 
incubated for 3.5 hours at 50 °C in a moisture chamber in 
hybridization solution, containing the antisense 35S-Labelled 
RNA probe (either CO or TH). After post-hybridization, 
sections were treated with formamide and RNAse, and 
then rinsed in 2xSSC, dehydrated in increasing solutions of 
ethanol, delipidated in xylene and air dried. Then, sections 
were coated with nuclear tract emulsion (Kodak NTB2), 
exposed for 4 weeks until development, counterstained with 
Nissl, delipidated and cover-slipped with Ralmount (BDH 
Ltd, Poole, Dorset, England) (Kastner et al 1994; Herrero 
et al 1996; Vila et al 1996, 1997). TH and CO mRNA expres-
sion were measured quantifying the optical density of silver 
grains of each neuron in the LC and DRN, respectively. 
Quantiﬁ  cation of the optical density was performed under 
bright ﬁ  eld microscope light with a 40x objective (Nikon) 
deﬁ  ning the perimeter of each neuron and using computer 
software (Scion Image) as described previously (Herrero et al 
1996; Barcia et al 2004). Data were expressed as mean ± 
SEM. Differences in mRNA expression between suicide vic-
tims and control subjects were analyzed by Student t-test.
Quantitative analysis revealed a statistically signiﬁ  cant 
increase in CO mRNA expression in the DRN of suicide vic-
tims compared with controls subjects. In contrast, TH mRNA 
expression in LC showed no statistically signiﬁ  cant difference 
between suicide victims and control subjects (Figure 1).
The increase in CO mRNA expression observed in the 
DRN of suicide victims is indicative of unspeciﬁ  ed physi-
ological activity of the serotonin neurons, in apparent con-
tradiction with the gener ally accepted ﬁ  nding of decreased 
serotonin content (Bourne et al 1968; Arango et al 1992; 
Nordstrom and Asberg 1992). However, post-mortem stud-
ies of suicide victims, using radio-ligand binding to quantify 
different types of 5-HT receptors, have demonstrated a 
signiﬁ  cant increase in 5-HT1A auto receptors in serotoner-
gic neurons from the DRN (Stockmeier et al 1998). The 
increased activity of DRN neurons reported in the present 
work may be related with the described increase of 5-HT1A 
receptor production (Stockmeier et al 1998). Since serotonin 
levels are generally decreased in the brain of suicide victims 
(Shaw et al 1967; Shaw 1967; Bourne et al 1968; Pare et al 
1969; Lloyd et al 1974; Arango et al 1992; Nordstrom and 
Asberg 1992; Mann et al 2000), the enhanced activity of 
DRN neurons might result in an increased energy demand, 
accompanied by depletion of the serotonin stores and over-
activity of reuptake mechanisms (Stockmeier et al 1998).
The mRNA TH levels in the LC reﬂ  ect previous results 
showing no differences in TH immunoreactivity between 
depressed suicide victims and normal subjects (Baumann 
et al 1999). However, these results seem to conﬂ  ict with 
previous studies reporting increased TH activity in the LC of 
suicide victims (Ordway et al 1994; Ordway 1997), although 
in the latter paper only two suicide victims with a premorbid 
diagnosis of depression were included, while the diagnosis Neuropsychiatric Disease and Treatment 2008:4(2) 415
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of the other seven suicides in the study group was uncertain. 
Taken together, these results suggest that there might be 
a dissociation between depression per se, which may be 
associated with reduced noradrenergic activity (Baumann 
et al 1999), and suicidal symptoms, which may be associated 
with increased activity (Ordway et al 1994), thus masking 
the effects on the post depression suicide victims.
Further studies are needed to elucidate the role of DRN 
and LC in suicide victims and how the activation of these 
nuclei is related with major depression and suicide attempts. 
Also, further clariﬁ  cation of the differences between differ-
ent subgroups of suicidal victims needs to be undertaken. 
Additional in vivo and post-mortem studies of subjects with 
a high risk of suicide are important in order to determine any 
clinical and physiological changes and to be able to prevent 
suicidal behavior.
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